search
Back to results

Magnetic Mini-Mover Procedure to Treat Pectus Excavatum (3MP)

Primary Purpose

Pectus Excavatum

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Magnetic Mini-Mover Procedure (3MP)
Magnatract (external magnet in a removable external brace)
3MP (Magnetic Mini-Mover Procedure)
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pectus Excavatum focused on measuring pectus excavatum, magnetic alteration, chest wall deformity

Eligibility Criteria

8 Years - 14 Years (Child)All SexesAccepts Healthy Volunteers

Residents of the United States with previously diagnosed pectus excavatum who are referred to the UCSF Pediatric Surgery Service for evaluation and treatment will be considered for participation in this study. Only patients with moderate to severe pectus excavatum who meet all the inclusion criteria will participate. The patient and family will be fully counseled and consented about the risks and benefits of participation in the study, and will be asked to sign an informed consent reviewed and approved by the UCSF Committee on Human Research.

Inclusion Criteria:

  1. Resident of the U.S.;
  2. Otherwise healthy male or female with pectus excavatum deformity;
  3. Between 8 and 14 years of age;
  4. Pectus Severity Index > 3.5 (normal 2.56); and
  5. Ability to read and speak English.

Exclusion Criteria:

  1. Other congenital anomalies (including significant skeletal anomalies such as scoliosis, bony fusion involving the cervical vertebrae) not directly related to pectus excavatum;
  2. Bleeding disorders;
  3. Heart disease (including arrhythmia);
  4. Persons with active implantable medical devices (AIMD) such as pacemakers;
  5. Persons with a relative(s) or close family friend(s) living within their households and having a pacemaker;
  6. Persons with arteriovenous malformations;
  7. Chest deformity more complicated than pectus excavatum (e.g.. Poland syndrome);
  8. Persons for whom a foreign body implant would pose a risk (e.g., immunodeficiency);
  9. Persons at increased risk for general anesthesia (e.g., history of malignant hyperthermia);
  10. Respiratory conditions that have required steroid treatment (e.g., prednisone)in the last 3 years;
  11. Pregnancy;
  12. Inability to understand or follow instructions;
  13. Refusal to wear the external brace;
  14. Inability to obtain pre-approval (authorization) from the patient's insurance carrier; and
  15. Inability or refusal to return to UCSF for weekly follow-up visits for the first month after surgery.

Sites / Locations

  • University of California, San Francisco

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

3MP - Treatment Arm

Arm Description

Magnetic Mini-Mover Procedure using the Magnimplant and Magnatract

Outcomes

Primary Outcome Measures

Affect on Cardiac Activity
EKG performed prior to implantation, one month post-implantation, and after explanation to evaluate whether magnetic field near the heart adversely affects cardiac activity. Outcome measure describes number of patients who experienced adverse change in EKG.
Damage/Discoloration to Skin
Outcome measure is number of patients who experienced permanent skin damage or discoloration due to external brace wear
Efficacy: Patient Satisfaction
Based on patient response to one-year post-explantation QoL questionnaire: How satisfied are you with the correction of your chest? Ratings: 5-very satisfied; 4-satisfied; 3-unsure; 2-dissatisfied; 1-very dissatisfied
Efficacy: Patient Recommendation of Treatment
Based on patient response to one-year post-explantation QoL statement: "I would recommend this treatment for pectus excavatum (sunken chest) to someone else with pectus excavatum." Ratings: 5-strongly agree; 4-agree; 3-unsure; 2-disagree; 1-strongly disagree

Secondary Outcome Measures

Patient Compliance
Compliance measured by average number of hours per day external device was worn by patient, as measured by the data sensor and logging device built into external prosthetic

Full Information

First Posted
April 24, 2007
Last Updated
December 2, 2015
Sponsor
University of California, San Francisco
Collaborators
FDA Office of Orphan Products Development
search

1. Study Identification

Unique Protocol Identification Number
NCT00466206
Brief Title
Magnetic Mini-Mover Procedure to Treat Pectus Excavatum
Acronym
3MP
Official Title
Phase II Magnetic Alteration of Pectus Excavatum
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
April 2007 (undefined)
Primary Completion Date
May 2010 (Actual)
Study Completion Date
April 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, San Francisco
Collaborators
FDA Office of Orphan Products Development

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a medical research study. The study investigators have developed a method to gradually repair pectus excavatum (sunken chest) deformity by placing a magnet on the sternum (breastbone) and then applying an external magnetic force that will pull the sternum outward gradually. Potential candidates for this study are children and adolescents with a previously diagnosed congenital pectus excavatum (sunken chest) deformity who are otherwise healthy and are seeking corrective surgery for their condition. They will be residents of the U.S. and between the ages of 8 and 14 years of age. Potential candidates and their families will have already been counseled about this condition and about the standard way to repair this deformity. The purpose of this study is to test what effects, good and/or bad, placing an external/internal magnetic device has on correcting pectus excavatum deformity in children, and the safety of using such a device for treatment.
Detailed Description
Pectus excavatum is the most common congenital chest wall abnormality in children. Surgical correction requires a big operation under general anesthesia which forces the sternum forward and holds it in place using a metal chest wall strut. Deformation of the chest wall under great pressure may result in complications and potential relapses as well as postoperative pain requiring hospitalization for regional and narcotic anesthesia for up to a week. An alternative principle for correction of chest wall and other deformities is gradual (bit-by-bit) correction using minimal force applied over many months (like moving teeth with orthodontic braces). The hypothesis of this study is that constant outward force on the deformed cartilage in pectus excavatum will produce biologic reformation of cartilage and correction of the chest wall deformity. The study investigators have developed a novel method of achieving gradual deformation/reformation of chest wall cartilage without the need for transdermal orthopedic devices or repeated surgeries. A magnetic force field is used to apply controlled, sustained force to promote biologic reformation of structural cartilage (the same principle as distraction osteogenesis). A magnet is implanted on the sternum and secured using a novel fixation strategy that can be accomplished through a 3-cm subxyphoid incision as a brief outpatient procedure. The magnet (and sternum) is pulled outward by another magnet suspended in a novel, low-profile, lightweight device previously molded to the patient's anterior chest wall. The external magnet allows individual adjustment in small increments of the distance (and, thus, force) and orientation of the force applied to the sternum. The low-profile, non-obtrusive anterior chest wall prosthesis is held in place by the force field between the two magnets. The study objectives are to test the safety and probable benefit of this procedure in 10 otherwise healthy, young patients, between 8 years and 14 years of age, who have chosen to have this deformity corrected using this novel technique rather than the standard Ravitch or Nuss techniques. We will document the rate of correction by chest imaging and measurement of the Pectus Severity Index. The study investigators will document safety and efficacy with an EKG prior to implantation, one month post-implantation, and finally after the magnet is removed, as well as patient and family satisfaction with a post-procedure Quality of Life-type survey.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pectus Excavatum
Keywords
pectus excavatum, magnetic alteration, chest wall deformity

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
3MP - Treatment Arm
Arm Type
Experimental
Arm Description
Magnetic Mini-Mover Procedure using the Magnimplant and Magnatract
Intervention Type
Device
Intervention Name(s)
Magnetic Mini-Mover Procedure (3MP)
Other Intervention Name(s)
3MP
Intervention Description
A rare earth magnet encased in FDA-approved titanium will be implanted securely on the outer surface of the lower end of the sternum in patients with pectus excavatum. This is accomplished as an outpatient procedure, under brief general anesthesia. A 2-inch transverse skinline incision is made at the junction of the sternum and xyphoid and the space in front and behind the sternum is dissected bluntly. The titanium can containing the magnet is securely fixed to the sternum by screwing it into a titanium fixation disk in front of the sternum. The procedure takes 1/2-hour, and the patient can go home the same day. In another outpatient procedure, the Magnimplant is explanted 18 months after implantation.
Intervention Type
Device
Intervention Name(s)
Magnatract (external magnet in a removable external brace)
Other Intervention Name(s)
Magnetic Mini-mover
Intervention Description
An external orthotic device "Magnatract" which includes an external magnet in a removable brace is fitted specifically to the patient's chest wall deformity. A calibrated meter in the external device measures the force applied between the two magnets. When the patient and family are comfortable with the device and comfort and skin condition have been assessed, the patient will be allowed to take the Magnatract home and begin the process of gradually advancing the sternum forward as the abnormal costal cartilage is reformed.
Intervention Type
Procedure
Intervention Name(s)
3MP (Magnetic Mini-Mover Procedure)
Other Intervention Name(s)
3MP
Intervention Description
Subject has EKG performed to measure baseline cardiac activity. Magnimplant is implanted. After one week, "Magnatract" is fitted. Chest x-ray and 2nd EKG performed 30 days post-implantation. Patient and parents complete QoL questionnaire 30d post-implantation. Patient seen weekly for first month post-implantation to assess comfort and skin condition. Thereafter, will be seen monthly. At each monthly visit, patient will have lateral and anterior-posterior chest X-rays to monitor sternal correction. At each visit data logger is downloaded to measure strength of pull since last visit and amount of wear-time. Magnimplant explanted 18 months later as 1/2-hr outpatient procedure. CT scan and third EKG performed after explanation. Patient and parents complete QOL questionnaires after explantation and 1 yr post-explantation.
Primary Outcome Measure Information:
Title
Affect on Cardiac Activity
Description
EKG performed prior to implantation, one month post-implantation, and after explanation to evaluate whether magnetic field near the heart adversely affects cardiac activity. Outcome measure describes number of patients who experienced adverse change in EKG.
Time Frame
One month post-explantation
Title
Damage/Discoloration to Skin
Description
Outcome measure is number of patients who experienced permanent skin damage or discoloration due to external brace wear
Time Frame
One-month post-explant
Title
Efficacy: Patient Satisfaction
Description
Based on patient response to one-year post-explantation QoL questionnaire: How satisfied are you with the correction of your chest? Ratings: 5-very satisfied; 4-satisfied; 3-unsure; 2-dissatisfied; 1-very dissatisfied
Time Frame
One year post-explant
Title
Efficacy: Patient Recommendation of Treatment
Description
Based on patient response to one-year post-explantation QoL statement: "I would recommend this treatment for pectus excavatum (sunken chest) to someone else with pectus excavatum." Ratings: 5-strongly agree; 4-agree; 3-unsure; 2-disagree; 1-strongly disagree
Time Frame
One year post-explanation
Secondary Outcome Measure Information:
Title
Patient Compliance
Description
Compliance measured by average number of hours per day external device was worn by patient, as measured by the data sensor and logging device built into external prosthetic
Time Frame
18 months active Rx

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Residents of the United States with previously diagnosed pectus excavatum who are referred to the UCSF Pediatric Surgery Service for evaluation and treatment will be considered for participation in this study. Only patients with moderate to severe pectus excavatum who meet all the inclusion criteria will participate. The patient and family will be fully counseled and consented about the risks and benefits of participation in the study, and will be asked to sign an informed consent reviewed and approved by the UCSF Committee on Human Research. Inclusion Criteria: Resident of the U.S.; Otherwise healthy male or female with pectus excavatum deformity; Between 8 and 14 years of age; Pectus Severity Index > 3.5 (normal 2.56); and Ability to read and speak English. Exclusion Criteria: Other congenital anomalies (including significant skeletal anomalies such as scoliosis, bony fusion involving the cervical vertebrae) not directly related to pectus excavatum; Bleeding disorders; Heart disease (including arrhythmia); Persons with active implantable medical devices (AIMD) such as pacemakers; Persons with a relative(s) or close family friend(s) living within their households and having a pacemaker; Persons with arteriovenous malformations; Chest deformity more complicated than pectus excavatum (e.g.. Poland syndrome); Persons for whom a foreign body implant would pose a risk (e.g., immunodeficiency); Persons at increased risk for general anesthesia (e.g., history of malignant hyperthermia); Respiratory conditions that have required steroid treatment (e.g., prednisone)in the last 3 years; Pregnancy; Inability to understand or follow instructions; Refusal to wear the external brace; Inability to obtain pre-approval (authorization) from the patient's insurance carrier; and Inability or refusal to return to UCSF for weekly follow-up visits for the first month after surgery.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael R Harrison, MD
Organizational Affiliation
University of California, San Francisco Medical Center and Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94143-0570
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
13295996
Citation
RAVITCH MM. The operative treatment of pectus excavatum. J Pediatr. 1956 Apr;48(4):465-72. doi: 10.1016/s0022-3476(56)80075-9. No abstract available.
Results Reference
background
PubMed Identifier
13588724
Citation
WELCH KJ. Satisfactory surgical correction of pectus excavatum deformity in childhood; a limited opportunity. J Thorac Surg. 1958 Nov;36(5):697-713. No abstract available.
Results Reference
background
PubMed Identifier
1616728
Citation
Morshuis WJ, Mulder H, Wapperom G, Folgering HT, Assman M, Cox AL, van Lier HJ, Vincent JG, Lacquet LK. Pectus excavatum. A clinical study with long-term postoperative follow-up. Eur J Cardiothorac Surg. 1992;6(6):318-28; discussion 328-9. doi: 10.1016/1010-7940(92)90149-r.
Results Reference
background
PubMed Identifier
13681493
Citation
ADKINS PC, BLADES B. A stainless steel strut for correction of pectus escavatum. Surg Gynecol Obstet. 1961 Jul;113:111-3. No abstract available.
Results Reference
background
PubMed Identifier
8641129
Citation
Shamberger RC. Congenital chest wall deformities. Curr Probl Surg. 1996 Jun;33(6):469-542. doi: 10.1016/s0011-3840(96)80005-0. No abstract available.
Results Reference
background
PubMed Identifier
12368998
Citation
Nuss D, Croitoru DP, Kelly RE Jr, Goretsky MJ, Nuss KJ, Gustin TS. Review and discussion of the complications of minimally invasive pectus excavatum repair. Eur J Pediatr Surg. 2002 Aug;12(4):230-4. doi: 10.1055/s-2002-34485.
Results Reference
background
PubMed Identifier
5038952
Citation
Beiser GD, Epstein SE, Stampfer M, Goldstein RE, Noland SP, Levitsky S. Impairment of cardiac function in patients with pectus excavatum, with improvement after operative correction. N Engl J Med. 1972 Aug 10;287(6):267-72. doi: 10.1056/NEJM197208102870602. No abstract available.
Results Reference
background
PubMed Identifier
12778393
Citation
Lawson ML, Cash TF, Akers R, Vasser E, Burke B, Tabangin M, Welch C, Croitoru DP, Goretsky MJ, Nuss D, Kelly RE Jr. A pilot study of the impact of surgical repair on disease-specific quality of life among patients with pectus excavatum. J Pediatr Surg. 2003 Jun;38(6):916-8. doi: 10.1016/s0022-3468(03)00123-4.
Results Reference
background
PubMed Identifier
2294364
Citation
Wynn SR, Driscoll DJ, Ostrom NK, Staats BA, O'Connell EJ, Mottram CD, Telander RL. Exercise cardiorespiratory function in adolescents with pectus excavatum. Observations before and after operation. J Thorac Cardiovasc Surg. 1990 Jan;99(1):41-7.
Results Reference
background
PubMed Identifier
10836238
Citation
Haller JA Jr, Loughlin GM. Cardiorespiratory function is significantly improved following corrective surgery for severe pectus excavatum. Proposed treatment guidelines. J Cardiovasc Surg (Torino). 2000 Feb;41(1):125-30.
Results Reference
background
PubMed Identifier
10657820
Citation
Zhao L, Feinberg MS, Gaides M, Ben-Dov I. Why is exercise capacity reduced in subjects with pectus excavatum? J Pediatr. 2000 Feb;136(2):163-7. doi: 10.1016/s0022-3476(00)70096-5.
Results Reference
background
PubMed Identifier
4073662
Citation
Mead J, Sly P, Le Souef P, Hibbert M, Phelan P. Rib cage mobility in pectus excavatum. Am Rev Respir Dis. 1985 Dec;132(6):1223-8. doi: 10.1164/arrd.1985.132.6.1223.
Results Reference
background
PubMed Identifier
10803331
Citation
Shamberger RC. Cardiopulmonary effects of anterior chest wall deformities. Chest Surg Clin N Am. 2000 May;10(2):245-52, v-vi.
Results Reference
background
PubMed Identifier
12970011
Citation
Malek MH, Fonkalsrud EW, Cooper CB. Ventilatory and cardiovascular responses to exercise in patients with pectus excavatum. Chest. 2003 Sep;124(3):870-82. doi: 10.1378/chest.124.3.870.
Results Reference
background
PubMed Identifier
10693675
Citation
Hebra A, Swoveland B, Egbert M, Tagge EP, Georgeson K, Othersen HB Jr, Nuss D. Outcome analysis of minimally invasive repair of pectus excavatum: review of 251 cases. J Pediatr Surg. 2000 Feb;35(2):252-7; discussion 257-8. doi: 10.1016/s0022-3468(00)90019-8.
Results Reference
background
PubMed Identifier
15017558
Citation
Park HJ, Lee SY, Lee CS. Complications associated with the Nuss procedure: analysis of risk factors and suggested measures for prevention of complications. J Pediatr Surg. 2004 Mar;39(3):391-5; discussion 391-5. doi: 10.1016/j.jpedsurg.2003.11.012.
Results Reference
background
PubMed Identifier
15868580
Citation
Weber TR. Further experience with the operative management of asphyxiating thoracic dystrophy after pectus repair. J Pediatr Surg. 2005 Jan;40(1):170-3. doi: 10.1016/j.jpedsurg.2004.09.039.
Results Reference
background
PubMed Identifier
12375767
Citation
Fonkalsrud EW, Reemtsen B. Force required to elevate the sternum of pectus excavatum patients. J Am Coll Surg. 2002 Oct;195(4):575-7. doi: 10.1016/s1072-7515(02)01245-0. No abstract available.
Results Reference
background
PubMed Identifier
9628377
Citation
Kowalewski J, Barcikowski S, Brocki M. Cardiorespiratory function before and after operation for pectus excavatum: medium-term results. Eur J Cardiothorac Surg. 1998 Mar;13(3):275-9. doi: 10.1016/s1010-7940(97)00326-6.
Results Reference
result

Learn more about this trial

Magnetic Mini-Mover Procedure to Treat Pectus Excavatum

We'll reach out to this number within 24 hrs